Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureSarah Siddiquah, Hanzla Shaz, Imtaiyaz Hassan
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
Winning the arms race by improving drug discovery against mutating targets
10.1021/cb200394t · 2012
The process of structure-based drug design
10.1016/j.chembiol.2003.09.002 · 2003
Structure-guided drug discovery: back to the future
10.1038/s41594-024-01244-3 · 2024
Unresolved referenced work
2021
Hit me with your best shot: Integrated hit discovery for the next generation of drug targets
10.1016/j.drudis.2024.104143 · 2024
Protein structure prediction and structural genomics
10.1126/science.1065659 · 2001
Structural biology in antiviral drug discovery
10.1016/j.coph.2016.08.014 · 2016
A structure-based drug discovery paradigm
10.3390/ijms20112783 · 2019
Strategies and challenges for the next generation of antibody–drug conjugates
10.1038/nrd.2016.268 · 2017
Research in the field of drug design and development
10.3390/ph16091283 · 2023
The current role and evolution of X-ray crystallography in drug discovery and development
10.1080/17460441.2023.2246881 · 2023
Molecular mechanisms of antibiotic resistance
10.1038/nrmicro3380 · 2015
Chemical screening by time-resolved X-ray scattering to discover allosteric probes
10.1038/s41589-024-01609-1 · 2024
Evolving SAXS versatility: solution X-ray scattering for macromolecular architecture, functional landscapes, and integrative structural biology
10.1016/j.sbi.2019.04.004 · 2019
Next generation antibody drugs: pursuit of the 'high-hanging fruit'
10.1038/nrd.2017.227 · 2018
Regulation of protein-ligand binding affinity by hydrogen bond pairing
10.1126/sciadv.1501240 · 2016
Molecular interactions in biological systems: technological applications and innovations
10.5376/cmb.2024.14.0021 · 2024
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
2020
Kinase drug discovery 20 years after imatinib: progress and future directions
10.1038/s41573-021-00195-4 · 2021
Comprehensive detection and characterization of human druggable pockets through binding site descriptors
10.1038/s41467-024-52146-3 · 2024
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
10.1126/science.abb4489 · 2020
Contribution of hydrophobic interactions to protein mechanical stability
10.1016/j.csbj.2022.04.025 · 2022
ADMET modeling approaches in drug discovery
10.1016/j.drudis.2019.03.015 · 2019
A systematic analysis of atomic protein-ligand interactions in the PDB
10.1039/c7md00381a · 2017
Protein structure prediction with energy minimization and deep learning approaches
10.1007/s11047-023-09943-4 · 2023
Bivalent mTOR inhibitors — the next generation
10.1038/nrd.2016.134 · 2016
A computational study of cation-π interactions vs salt bridges in aqueous media: implications for protein engineering
10.1021/ja991755c · 2000
Deep learning in drug discovery
10.1002/minf.201501008 · 2016
Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: a structural review
10.1016/j.molliq.2022.118901 · 2022
Homology modeling in the time of collective and artificial intelligence
10.1016/j.csbj.2020.11.007 · 2020
ρ-σ-π Analysis. a method for the correlation of biological activity and chemical structure
10.1021/ja01062a035 · 1964
Structure-based methods for predicting target mutation-induced drug resistance and rational drug design to overcome the problem
10.1016/j.drudis.2012.06.018 · 2012
Cross-Talk of Cation−π interactions with electrostatic and aromatic interactions: a salt-dependent trade-off in biomolecular condensates
10.1021/acs.jpclett.3c01642 · 2023
Chemprop: a machine learning package for chemical property prediction
10.1021/acs.jcim.3c01250 · 2024
ADMET—turning chemicals into drugs
10.1038/90761 · 2001
Molecular recognition: lock-and-key, induced fit, and conformational selection
2013
A hierarchical approach to all-atom protein loop prediction
10.1002/prot.10613 · 2004
A hierarchical approach to all-atom protein loop prediction
10.1002/prot.10613 · 2004
Highly accurate protein structure prediction with AlphaFold
10.1038/s41586-021-03819-2 · 2021
Evolving cryo-EM structural approaches for GPCR drug discovery
10.1016/j.str.2021.04.008 · doi-reference
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
10.1038/s41392-024-01803-6 · doi-reference
Targeting cancer with small molecule kinase inhibitors
10.1038/nrc2559 · doi-reference
Drug design: where we are and future prospects
10.3390/molecules26227061 · doi-reference
Protein structure and function prediction using I-TASSER
10.1002/0471250953.bi0508s52 · doi-reference
G protein-coupled receptors: structure- and function-based drug discovery
10.1038/s41392-020-00435-w · doi-reference
Uncovering the dominant motion modes of allosteric regulation improves allosteric site prediction
10.1021/acs.jcim.1c01267 · doi-reference
Fast NMR-based determination of the 3D structure of the binding site of protein–ligand complexes with weak affinity binders
10.1002/anie.201612304 · doi-reference
Protein structure modeling with MODELLER
10.1007/978-1-4939-7231-9_4 · doi-reference
SWISS-MODEL: homology modelling of protein structures and complexes
10.1093/nar/gky427 · doi-reference
Structure-based drug design: progress, results and challenges
10.1016/s0969-2126(00)00060-5 · doi-reference
Computational approach for protein structure prediction
10.4258/hir.2013.19.2.137 · doi-reference
AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models
10.1093/nar/gkab1061 · doi-reference
Applications of machine learning in drug discovery and development
10.1038/s41573-019-0024-5 · doi-reference
Cryptic binding sites on proteins: definition, detection, and druggability
10.1016/j.cbpa.2018.05.003 · doi-reference
Progress in small-angle scattering from biological solutions at high-brilliance synchrotrons
10.1107/s2052252517008740 · doi-reference
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
10.1002/jcc.21334 · doi-reference
Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR
10.1038/s41573-023-00832-0 · doi-reference
Computational modeling of protein–ligand interactions: from binding site identification to pose prediction and beyond
10.1016/j.sbi.2025.103152 · doi-reference
Conformational ensembles of the human intrinsically disordered proteome
10.1038/s41586-023-07004-5 · doi-reference
In silico comparative study of the anti-cancer potential of inhibitors of glucose-6-phosphate dehydrogenase enzyme using ADMET analysis, molecular docking, and molecular dynamic simulation
10.1002/adts.202400757 · doi-reference
Tetraspanins: structure, dynamics, and principles of partner-protein recognition
10.1016/j.tcb.2023.09.003 · doi-reference
Current NMR techniques for structure-based drug discovery
10.3390/molecules23010148 · doi-reference
Binding affinity determination in drug design: insights from lock and key, induced fit, conformational selection, and inhibitor trapping models
10.3390/ijms25137124 · doi-reference
The role of tryptophan in π interactions in proteins: an experimental approach
10.1021/jacs.2c04986 · doi-reference
Generating focused molecule libraries for drug discovery with recurrent neural networks
10.1021/acscentsci.7b00512 · doi-reference
Protein–ligand interactions: recent advances in biophysics, biochemistry, and bioinformatics
10.3390/ijms26199576 · doi-reference
SWISS-MODEL: an automated protein homology-modeling server
10.1093/nar/gkg520 · doi-reference
Modelling three-dimensional protein structures for applications in drug design
10.1016/j.drudis.2013.10.027 · doi-reference
Properties of FDA-approved small molecule protein kinase inhibitors: a 2026 update
10.1016/j.phrs.2026.108107 · doi-reference
Cryo-EM in drug discovery: achievements, limitations and prospects
10.1038/nrd.2018.77 · doi-reference
Understanding the structural mechanisms of antibiotic resistance sets the platform for new discovery
10.2217/fmb.15.78 · doi-reference
Extending quantum-mechanical benchmark accuracy to biological ligand-pocket interactions
10.1038/s41467-025-63587-9 · doi-reference
Assessing protein homology models with docking reproducibility
10.1016/j.jmgm.2023.108430 · doi-reference
Virus structure and structure-based antivirals
10.1016/j.coviro.2021.09.005 · doi-reference
High-throughput and in silico screenings in drug discovery
10.1517/17460440903190961 · doi-reference
Rescoring and linearly combining: a highly effective consensus strategy for virtual screening campaigns
10.3390/ijms20092060 · doi-reference
Fast and accurate Ab initio protein structure prediction using deep learning potentials
10.1371/journal.pcbi.1010539 · doi-reference
mRNA vaccines — a new era in vaccinology
10.1038/nrd.2017.243 · doi-reference
The development of cryo-EM into a mainstream structural biology technique
10.1038/nmeth.3694 · doi-reference